The startup develops a medical technology platform featuring smart implantable flow reduction devices aimed at improving heart micro-perfusion in patients with refractory angina. This technology provides a solution for individuals who have not found relief through existing medical therapies, enabling them to regain control over their daily lives.
Funding
$6.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Millions of individuals worldwide suffer from coronary microvascular dysfunction, experiencing persistent chest pain, pressure, and shortness of breath. Existing medical therapies often fail to provide adequate relief for these patients, significantly impacting their quality of life.
Solution
VahatiCor's A-FLUX Reducer System, featuring Swiftcell Technology, is a minimally invasive interventional therapy designed to alleviate symptoms of coronary microvascular dysfunction. The system utilizes a self-expanding device implanted in the coronary sinus to redistribute blood flow and reduce pressure in the heart. Swiftcell Technology is engineered for rapid patient response, with a variable cell structure optimized for immediate blood flow redistribution. The device's hourglass shape is intended to provide robust performance regardless of patient anatomy, while its shape-memory material is designed to conform seamlessly to the coronary sinus for proper placement and long-term retention.
Target Audience
The primary target audience includes interventional cardiologists and patients suffering from coronary microvascular dysfunction who have not found relief through existing medical therapies.
Features
- Minimally-invasive, self-expanding A-FLUX Reducer device for implantation in the coronary sinus.
- SwiftCell Technology designed for rapid and targeted therapy.
- Variable cell structure optimized to redistribute cardiac blood flow immediately upon delivery.
- Hourglass shape intended to provide robust performance, regardless of anatomy.
- Shape-memory material designed to conform seamlessly to the coronary sinus for proper placement and long-term retention.
- Delivery system intended to provide reliable, straightforward delivery of reducer implant.